相似文献
1
Lung cancer immunotherapy.
Clin Med Res. 2005 Nov;3(4):221-8. doi: 10.3121/cmr.3.4.221.
2
Prostate cancer vaccines: current status.
Semin Oncol. 1999 Apr;26(2):192-201.
3
Early clinical trial experience with vaccine therapies in non-small-cell lung cancer.
Clin Lung Cancer. 2008 Feb;9 Suppl 1:S20-7. doi: 10.3816/clc.2008.s.004.
4
Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Cancer Control. 2013 Jan;20(1):22-31. doi: 10.1177/107327481302000105.
5
Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.
Gen Thorac Cardiovasc Surg. 2009 Sep;57(9):449-57. doi: 10.1007/s11748-008-0433-6. Epub 2009 Sep 13.
6
Immunotherapy for non-small-cell lung cancer.
Expert Opin Biol Ther. 2014 Aug;14(8):1061-4. doi: 10.1517/14712598.2014.925874. Epub 2014 May 30.
7
Lung cancer: potential targets for immunotherapy.
Lancet Respir Med. 2013 Sep;1(7):551-63. doi: 10.1016/S2213-2600(13)70159-0. Epub 2013 Aug 23.
8
[Vaccines for the treatment of non-small cell lung cancer].
Rev Mal Respir. 2019 Mar;36(3):415-425. doi: 10.1016/j.rmr.2018.12.003. Epub 2019 Mar 20.
9
Immunotherapy for lung cancer.
J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S164-70. doi: 10.1097/JTO.0b013e318174e9a7.
10
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Future Oncol. 2014 Jan;10(1):79-90. doi: 10.2217/fon.13.145.
引用本文的文献
1
Autoimmune side-effect of immunotherapy in lung cancer treatment revealed from large-scale cohort.
medRxiv. 2024 Dec 5:2024.12.03.24318450. doi: 10.1101/2024.12.03.24318450.
2
Pembrolizumab monotherapy survival benefits in metastatic non-small-cell lung cancer: a systematic review of real-world data.
Discov Oncol. 2024 Jul 24;15(1):303. doi: 10.1007/s12672-024-01153-3.
3
Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine.
Front Immunol. 2023 Mar 28;14:1130054. doi: 10.3389/fimmu.2023.1130054. eCollection 2023.
4
Novel Mouse Models for Cancer Immunology.
Annu Rev Cancer Biol. 2022 Apr;6(1):269-291. doi: 10.1146/annurev-cancerbio-070620-105523. Epub 2022 Jan 18.
5
Anti-Tumor Effect of Somatic Antigen on Inhibition Cell Growth of K562.
Iran J Parasitol. 2022 Jan-Mar;17(1):28-35. doi: 10.18502/ijpa.v17i1.9013.
6
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
Medicina (Kaunas). 2022 Jan 7;58(1):90. doi: 10.3390/medicina58010090.
7
A mouse model for the study of anti-tumor T cell responses in Kras-driven lung adenocarcinoma.
Cell Rep Methods. 2021 Sep 27;1(5). doi: 10.1016/j.crmeth.2021.100080. Epub 2021 Sep 16.
8
BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI148291.
9
Repurposing Infectious Diseases Vaccines Against Cancer.
Front Oncol. 2021 May 13;11:688755. doi: 10.3389/fonc.2021.688755. eCollection 2021.
10
Downregulated expression of human leukocyte antigen class I heavy chain is associated with poor prognosis in non-small-cell lung cancer.
Oncol Lett. 2019 Jul;18(1):117-126. doi: 10.3892/ol.2019.10293. Epub 2019 Apr 30.
本文引用的文献
1
Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.
Cancer. 2005 Apr 15;103(8):1670-5. doi: 10.1002/cncr.20950.
2
Immunotherapy for advanced renal cell cancer.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD001425. doi: 10.1002/14651858.CD001425.pub2.
3
Cancer statistics, 2005.
CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. doi: 10.3322/canjclin.55.1.10.
4
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6094-100. doi: 10.1158/1078-0432.CCR-04-0482.
5
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13885-90. doi: 10.1073/pnas.0405884101. Epub 2004 Sep 13.
6
Autologous dendritic cell vaccines for non-small-cell lung cancer.
J Clin Oncol. 2004 Jul 15;22(14):2808-15. doi: 10.1200/JCO.2004.01.074.
7
Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.
J Clin Oncol. 2004 Jul 15;22(14):2800-7. doi: 10.1200/JCO.2004.10.197.
8
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group.
J Clin Oncol. 2004 Jun 1;22(11):2122-32. doi: 10.1200/JCO.2004.08.083.
9
10
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
J Immunol. 2004 Mar 1;172(5):3289-96. doi: 10.4049/jimmunol.172.5.3289.
Zotero 插件